Air quality remains ‘very poor’ as fog engulfs Delhi
New Delhi (India): Delhiites woke up to a thick blanket of fog on Monday morning amid falling temperatures, while the air quality in the national capital continued to be in…
Lupin gets EIR from USFDA for Pithampur facility unit
Drug firm Lupin on Monday said it has received an Establishment Inspection Report (EIR) from the US health regulator for a unit of its Pithampur facility in Madhya Pradesh. The…
China biotech Junshi Biosciences seeks up to $414mln in Hong Kong IPO
By Julia Fioretti HONG KONG: Chinese biotech company Shanghai Junshi Biosciences is seeking up to $414 million in a Hong Kong initial public offering (IPO), making it the latest company…
FDA clears Pear Therapeutics’ mobile app to help treat opioid abuse
The U.S. Food and Drug Administration on Monday cleared Pear Therapeutics’ mobile application to help increase retention of patients undergoing outpatient treatment for opioid abuse. The reSET-O app is a…
Supernus Pharma’s ADHD treatment meets main goal in two studies
Supernus Pharmaceuticals Inc on Thursday said its experimental treatment for attention deficit hyperactivity disorder met the main goal of reducing symptoms in affected children from six to 11 years of…
In pharmaceutical tubing, the chemical property defines the glass : Georg Sparschuh
Shahid Akhter, editor, ET Healthworld spoke to Georg Sparschuh, Managing Director, Schott Glass India Pvt., Jambusar, Gujarat, to know more about the quality of glass used in pharmaceutical packaging. SCHOTT…
HUL unlikely to become the largest food company: Experts
NEW DELHI: Hindustan Unilever, the country’s largest consumer products company, is unlikely to become the largest food company despite its acquisition of GSK Consumer business including Horlicks, because it still…
Maha FDA Yet To Set Up NPPA Cell To Detect Ceiling Price Violation
The Maharashtra Food and Drug Administration (FDA) is yet to set up an NPPA cell to deal with the drug price ceiling violation at its headquarters in Mumbai for want…
USFDA recommends regulatory action after Jubilant Life’s Roorkee plant inspection
New Delhi: The US health regulator has recommended a regulatory or administrative action after the inspection of Roorkee manufacturing facility of drug firm Jubilant Life Sciences, according to a regulatory…
AstraZeneca’s Imfinzi fails to meet main goals in head and neck cancer study
AstraZeneca Plc’s immunotherapy treatment Imfinzi did not meet the main goals in a late-stage study for advanced head and neck cancer, the London-listed drugmaker said on Friday. The study, known…
